Form 4: Astrana Health's Chief Accounting Officer Receives Stock Grants

Glenn Sobotka, Chief Accounting Officer of Astrana Health, Inc., reports the acquisition of restricted stock and performance-based restricted stock.

Summary

• Glenn Sobotka, the Chief Accounting Officer of Astrana Health, Inc., filed a Form 4 on March 28, 2025, reporting changes in beneficial ownership.
• The report details the acquisition of 6,432 shares of restricted stock and 8,269 shares of performance-based restricted stock on March 26, 2025.
• The restricted stock vests in four equal annual installments starting March 26, 2026, contingent upon continued employment.
• The performance-based restricted stock vests subject to achieving performance goals and time-based conditions, also contingent upon continued employment.
• Following these transactions, Sobotka beneficially owns 14,701 shares, including restricted stock.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The stock grants are a positive sign of incentivizing management, but also represent potential future dilution.

Positives

• The grant of restricted stock and performance-based restricted stock to a key officer like the Chief Accounting Officer can be seen as an incentive to align their interests with the long-term success of the company.
• The vesting schedules tied to continued employment and performance goals suggest a focus on retaining key personnel and driving performance.

Risks

• The vesting of the restricted stock is contingent upon continued employment, creating a potential risk if the officer leaves the company before the vesting dates.
• The performance-based restricted stock is subject to the achievement of applicable performance goals, which may or may not be met.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the stock grants suggest a multi-year commitment from the executive.

Industry Context

Stock grants are a common practice in the healthcare industry to incentivize and retain key executives. The specific terms of the grants, such as vesting schedules and performance goals, are tailored to the company's specific circumstances and strategic objectives.

Comparison to Industry Standards

• Stock grants are a common component of executive compensation packages across various industries, including healthcare.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize stock grants as part of their executive compensation plans.
• The vesting schedules and performance metrics associated with these grants vary depending on the company's specific goals and industry practices.

Stakeholder Impact

• Shareholders may experience slight dilution over time as the restricted stock vests.
• Employees may view the stock grants as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Form 4, beneficial ownership, restricted stock, performance-based restricted stock, Astrana Health, ASTH, Glenn Sobotka, Chief Accounting Officer, stock grant, vesting